跳至主要内容
临床试验/NCT00640731
NCT00640731Unknown4 期

Study of the OmniWave Endovascular System in Subjects With Lower and Upper Extremity Deep Vein Thrombosis - SONIC I Study

OmniSonics Medical Technologies, Inc.0 个研究点目标入组 50 人开始时间: 2008年3月1日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
50
主要终点
Procedural success rate defined as at least 50% reduction in thrombus burden in each target treatment zone following use of the OmniWave Endovascular System

研究概览

简要总结

This is a prospective, multi-center single arm registry to assess the use of the OmniWave Endovascular System in subjects presenting with either lower or upper extremity acute (symptoms have been present for greater than or equal to 14 days) DVT.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • DVT confirmed by venographic and ultrasound imaging, which has been symptomatic for a maximum of 14 days, or diagnosed within past 14 days defined as either first episode (no prior history in affected segment), or recurrent episode.
  • Written informed consent
  • Agreement to comply with follow up requirements

排除标准

  • Known R-L shunt, pulmonary A-V malformation
  • Excessive tortuosity and/or sharp angulation in target treatment zone
  • Isolated calf vein thrombosis
  • Isolated DVT in veins peripheral to axillary vein
  • Thrombus in peripheral vessel smaller than 5 mm
  • Target treatment zone cannot be adequately accessed within the 100 cm working length of device

结局指标

主要结局

Procedural success rate defined as at least 50% reduction in thrombus burden in each target treatment zone following use of the OmniWave Endovascular System

时间窗: Post-Index procedure

次要结局

  • Death, clinically detectable PE, significant vessel damage in target treatment area(through 6 months post-index procedure)
  • Restoration and maintenance of antegrade in-line flow in target treatment area(through 6 months post-index procedure)
  • QOL SF-36(through 6 months post-index procedure)
  • Incidence of clinically significant hemolysis(Prior to discharge)

研究者

发起方
OmniSonics Medical Technologies, Inc.
申办方类型
Other

相似试验